West nile virus

Encephalitis: Diagnosis and Treatment

Volumn , Issue , 2007, Pages 133-155

  Asnis, Deborah S ^a   Crupi, Robert S ^a  

^a FLUSHING HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85020741725     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (132)

1. Monath TP, Tsai TF. Flaviviruses. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. New York: Churchill Livingstone, 2002; 1097-151.
2. Lindenbach BD, Rice CM. Flaviviridae. In: Knipe DM, Howley PM, eds. The Viruses and their Replication. Fields Virology. Philadelphia: Lippicott, 2001: 991-1041.
3. Burke DS, Monath TP, Flaviviruses. In: Knipe DM, Howley, PM, eds. Clinical Virology. New York, NY: Lippincott, 2001:1043-125.
4. Smithburn KC, Hughes TP, Burke AW, et al. A neurotropic virus isolated from the blood of a native of Uganda. Amer Jour Trop Med 1940; 20:471-92.
5. Smithburn KC, Jacobs HR, Neutralization tests against neurotropic viruses with sera collected in Central Africa. J Immunol 1942; 44:9-23.
6. Smithburn KC. Neutralizing antibodies against certain recently isolated viruses in sera of human beings residing in East Africa. J Immunol 1952; 69: 223-34.
7. Philip CV, Smadel JE. Transmission of West Nile virus by infected Aedes albopictus. Proc Soc Exp Biol Med 1943; 53:49-50.
8. Kitaoka M. Experimental transmission of the West Nile virus by the mosquito. Jap Med J 1950; 3:77-81.
9. Melnick JL, et al. Isolation from human sera in Egypt of virus apparently identical to West Nile virus. Proc Soc Exp Biol Med 1951; 77:661-5.
10. Taylor RM, Work TH, Hurlbu HS, et al. A study of the ecology of West Nile virus in Egypt. Am J Trop Med Hyg 1956; 5:579-620.
11. Bernkopf H, Levine S, Nerson R, Isolation of West Nile Virus In Israel. J Infect Dis 1953; 93:207-18.
12. Bernkopf H, Levine S. Isolation of a virus closely related to West Nile virus from the blood of a sick child during an epidemic in Maayan Zvi. Bull Research Counc Israel 1952; 2:209.
13. Goldblum N, Sterk VV, Jasinska-Klingberg W. The natural history of West Nile fever. II. Virological findings and the development of homologous and heterologous antibodies in West Nile infection in man. Am J Hyg 1957; 66: 363-80.
14. Spigland W, Jasinska-Klingberg W, Hofshi E, et al. Clinical and laboratory observations in an outbreak of West Nile fever in Israel. Harefuah 1958; 54: 275-81 (in Hebrew with English abstract).
15. McIntosh BM, Jupp PG, Dos Santos I, et al. Epidemics of West Nile and Sindbis viruses in South Africa with Culex univittatus theobold as a vector. S Afr J Sci 1976; 72:295-300.
16. Murgue B, Murri S, Triki H, et al. West Nile in the Mediterranean Basin. 1950-2000. Ann NY Acad 2001; 117-26.
17. Murgue B, Murri S, Zientara S, et al.WestNile virus outbreak in horses, southern France, 2000: The Return after 35 years. Emerg Infect Dis 2000; 7:692-6.
18. George S, Gourie-Devi M, Rao JA, et al. Isolation of West Nile virus from the brains of children who had died of encephalitis. Bulletin of the World Health Organization 1984; 62(6); 879-82.
19. Georges AJ, Lesbordes JL, Georges-Courbot MC, et al. Fatal hepatitis from West nile virus. Ann Inst Pasteur/Virol 1987; 138:237-44.
20. Le Guenno B, Bougemouh A, Azzam T, et al. West Nile: A deadly virus? Lancet 1996; 348:1315.
21. Tsai TF, Popovivi F, Cernescu C, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352:767-71.
22. Triki H, Murri S, Le Guenno B, et al. Encephalalite A Arbovirus West Nile en Tunisie. Med Trop 2001; 61:487-90.
23. Centers for Disease Control and Prevention. Outbreak of West Nile-like viral encephalitis: New York, 1999. MMWR Morb Mortal Wkly Rep 1999; 48: 845-9.
24. Asnis DS, Conetta R, Teixeira AA, et al. The West Nile virus outbreak of 1999 in New York: The flushing hospital experience. Clin Infect Dis 2000; 30: 413-18.
25. Asnis DA, West Nile virus infection in the United States: A review and update. Infect Med 2002; 19:266-78.
26. Nash D, Mostashari F, Fine A, et al. 1999 West Nile outbreak response working Group. The outbreak of West Nile virus infection, New York City area, 1999. N Engl J Med 2001; 344:1807-14.
27. Centers for Disease Control West Nile Virus information website. http://www.cdc.gov/ncidod/dvbid/westnile/index.htm (last accessed August 28, 2007).
28. Platonov AE, Shipulin GA, Shipulina OY, et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 2001; 7:128-32.
29. Lvov DK, Butenko AM, Gromashevsky VL, Larichev, VPh, Gaidamovich SY, et al. Isolation of two strains of West Nile virus during an outbreak in Southern Russia, 1999. Emerg Infect Dis 2000; 6:373-6.
30. Malkinson M, Banet C, Weisman Y, et al. Introduction of West Nile virus in the Middle East by migrating white storks. Emerg Infect Dis 2002; 8:392-7.
31. Giladi M, Metzkor-Cotter E, Martin DA, et al. West Nile encephalitis in Israel, 1999: The New York connection. Emerg Infect Dis 2001; 7(4): 659-61.
32. Bin H, Grossman Z, Pokamunski S, et al. West Nile fever in Israel 1999-2000 from Geese to Humans. Ann NY Acad Sci 2001; 951:127-42.
33. Health Canada. West Nile Virus Surveillance 2002: Canada. Infectious Diseases News Brief. Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada. June 7, 2002. Available at http:// www.hc-sc.gc.ca/pphb-dgspsp/bid-bmi/dsd-dsm/nb-ab/2002/nb2302_e.html.
34. Centers for Disease Control and Prevention. West Nile virus activity-United States 2001. Morbid Mortal Wkly rep 2002; 51:497-501.
35. Loreno-Pino MA, Giltvich BJ, Farfan-Ale JA, et al. Serologic evidence of West Nile virus infection in horses, Yucatan State, Mexico. Emerg Infect Dis 2003; 9:857-9.
36. Dupuis AP, Marra PP, Kramer LD, Serologic Evidence of West Nile virus transmission, Jamaica, West Indies. Emerg Infect Dis 2003; 9:860-3.
37. Komar O, Robbins MB, Klenk K, et al. West Nile virus transmission in resident birds, Dominican Republic. Emerg Infect Dis 2003; 9:1299-302.
38. Zeller HG, Schuffenecker. West Nile Virus: An overview of its spread in Europe and the Mediterranean Basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004; 23:147-56.
39. Estrada-Franco JG, Navarro-Lopez R, Beasley DWC, et al. West Nile virus in Mexico: Evidence of widespread circulation since July 2002. Emer Infect Dis 2003; 9:1604-7.
40. Depoortere E, Kavle J, Keur K, et al. Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002. Trop Med Int Health 2004; 9:730-36.
41. Petersen LR, Roehrig JT, West Nile virus: A reemerging global pathogen. Emer Infect Dis 2001; 7:611-4.
42. Tber, Abdelhaz A. West Nile fever in horses in Morocco. Bull O.I.E. 1996; 11: 867-9.
43. Cantile C, et al. Clinical and neuropathological features of West Nile virus equine encephalomyelitis in Italy. Equine Vet J 2000; 32:31-5.
44. Murgue B, et al. West Nile outbreak in horses in Southern France (2000): The return 35 years later. Emerg Infect Dis 2001; 7:692-6.
45. Chowers M, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7:675-8.
46. Weiss D, Carr D, Kellachan J, et al. West Nile virus outbreak response working group. Clinical findings of West Nile virus infection I hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001; 7:654-8.
47. Cernescu C, Ruta SM, Tardei G, et al. A high number of severe neurologic clinical forms during an epidemic of West Nile virus infection. Rom J Virol 1997; 48:13-25.
48. Eidson M, Komar N, Sorhage F, et al. West Nile virus avian mortality surveillance group. Crow deaths as a sentinel surveillance system for West Nile virus in the Northeastern United States, 1999. Emerg Infect Dis 2001; 7:615-20.
49. Hubalek Z, Comparative symptomatology of West Nile fever. Lancet 2001; 358:254-5.
50. Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the Northeastern United States. Science 1999; 286:2333-7.
51. Ebel GD, DupuisII AO, Ngo K, et al. Partial genetic characterization of West Nile virus strains, New York State, 2000. Emerg Infect Dis 2001; 7:650-3.
52. Turell MJ, Sardelis MR, Dohm DJ, et al. Potential North American vectors of West Nile virus. Ann NY Acad Sci 2001; 951:317-24.
53. Centers for Disease Control and Prevention. Update: Surveillance for West Nile virus in overwintering mosquitoes-New York, 2000. Morb Mortal Wkly Rep 2000; 49:178-9.
54. Higgs S, Bradley Schneider BS, Vanlandingham DL, et al. Nonviremic transmission of West Nile virus. Proc Natl Acad Sci USA 2005; 102(23).
55. Hubalek A, Halouzka J. West Nile Fever-A reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis 1999; 5(5):643-50.
56. Petersen LR, Marfin AA. West Nile virus: A primer for the clinician. Ann Intern Med 2002; 137:173-9.
57. Centers for Disease Control and Prevention. West Nile Virus-United States, November 14-20, 2002, and Missouri, January 1-Novermber 9, 2002. Morb Mortal Wkly Rep 2002; 51:1049-51.
58. Komar N, Pamella NA, Burns JE, et al. Serologic evidence for West Nile virus infection in birds in the New York City vicinity during an outbreak I 1999. Emerg Infect Dis 2001; 7:621-6.
59. Garmendia AE, Van Kruiningen HJ, French RA, et al. Recovery and identification of West Nile virus from a hawk in winter. J Clin Microbiol 2000; 38:3110-1.
60. Peiris JSM, Amerasinghe FP. West Nile fever. In: Beran GW, Steele JH. Handbook of Zoonoses Section B: Viral. Boca Raton, Florida: CRC Press, 1994:139-48.
61. Miller DL, Mauel MJ, Baldwin C, et al. West Nile virus in farmed alligators. Emerg Infect Dis 2003; 9:794-9.
62. NirYD. Airborne West Nile virus infection.AmJ Trop Med Hyg 1959; 8:537-9.
63. Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections-United States, 2002. Morb Mortal Wkly Rep 2002, 51:1133-5.
64. Centers for Disease Control and Prevention. Investigations of West Nile virus infections in recipients of blood transfusions Morb Mortal Wkly Rep 2002; 51: 973-4.
65. Centers for Disease Control and Prevention Update. Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion. Morb Mortal Wkly Rep 2002; 51:833-6.
66. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. Morb Mortal Wkly Rep 2002; 51:879-80.
67. Centers for Disease Control and Prevention. Intrauterine West Nile virus infection-New York, 2002. Morb Mortal Wkly Rep 2002; 51:1135-6.
68. Centers for Disease Control and Prevention. Possible Dialysis-related West Nile virus transmission-Georgia, 2003. Morb Mortal Wkly Rep 2004; 53:738-9.
69. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42:1019-26.
70. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236-45.
71. Centers for Disease Control and Prevention. Update: West Nile virus screening of blood donations and transfusion-associated transmission- United States, 2003. 2004; 53:281-4.
72. Guidance for Industry: Revised Recommendations for the Assessment of Donor Suitability and Blood and Blood Product Safety in cases of Known or Suspected West Nile Virus Infection, FDA Final Guidance. (http://www.fda. gov/cher/gdlns/wnvguid.pdf)
73. The Practice Committee of the Society for Assisted Reproductive Technology and the Practice Committee of the American Society for Reproductive Medicine. American Society for Reproductive Medicine/Society for Assisted Reproductive Technology position statement on West Nile virus. Fertil Steril 2005; 83:527-8.
74. Iwamoto M, Jerrigan DB, Guasch A, et al. Transmission of West Nile virus from an organ door to four transplant recipients. N Eng J Med 2003; 348: 2196-203.
75. Kumar D, Drebot MA, Wong SJ, et al. A seroprevalence study of West Nile virus infection in solid organ transplant recipients. Am J Transplant 2004; 4: 1883-8.
76. Centers for Disease Control and Prevention. Interim guidelines for the evaluation of infants born to mothers infected with West Nile virus during pregnancy. Morb Mortal Wkly Rep 2004; 53:154-7.
77. Bruno J, Rabito FJ, Dildy GA. West Nile Virus meningoencephalitis during pregnancy. J La State Med Soc 2004; 156:204-5.
78. Hayes EB, O’Leary DR. West Nile virus infection: A pediatric perspective. Pediatrics 2004; 113:1375-81.
79. Corwin A, Habib M, Watts D, et al. Community-based prevalence profile of arboviral, rickettsial, and Hantaan-like viral antibody in the Nile River Delta of Egypt. Am J Trop Med Hyg 1993; 48:776-83.
80. Mostashari F, Bunning MI, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet 2001; 358:261-4.
81. Gadoth N, Weltzman S, Lehmann EE. Acute anterior myelitis complicating West Nile fever. Arch Neurol 1979; 36:172-3.
82. Southam CM, Moore AE. Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg 1954; 3:19-50.
83. Ahmed S, Libman R, Wesson K, et al. Guillain-Barré syndrome: An unusual presentation of West Nile virus infection. Neurology 2000; 55:144-6.
84. Leis AA, Stokic DS, Polk JL, et al. A Poliomyelitis-like syndrome from West Nile virus infection. N Eng J Med 2002; 347:1279-80.
85. Glass JD, Samuels O, Rich MM, Poliomyelitis due to West Nile virus. N Engl J Med 2002; 347:1280-1.
86. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290:511-5.
87. Burton JM, Kern RZ, Halliday W, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci 2004; 31:185-93.
88. Robinson RL, Shahida S, Madan N, et al. Transient Parkinsonism in West Nile virus encephalitis. Am J Med 2003; 115:252-3.
89. Solomon T, Fischer AF, Beasley DWC, et al. Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis 2003; 36:e140-5.
90. DellaBadia J, Jaffe SL, Singh L, et al. An occipital lobe epileptogenic focus in a patient with West Nile encephalitis. Eur J Neurol 2004; 11:111-3.
91. Hassin-baer S, Kirson ED, Shulman L, et al. Stiff-Person Syndrome Following West Nile fever. Arch Neurol 2004; 61:938-41.
92. Belensley AD, Jaffery SH, Collins H, et al. Bilateral diaphragmatic paralysis and related respiratory complications in a patient with West Nile virus infection. Thorax 2004; 59:268-69.
93. Bakri SJ, Kaiser PK. Ocular manifestations of West Nile virus. Curr Opin Ophthalmol 2004; 15:537-40.
94. Albagli C, Chalmoff R, A case of West Nile virus myocarditis. Harefuah 1959; 57:275-6.
95. Perelman A, Stern J. Acute pancreatitis in West Nile fever. Am J Trop Med Hyg 1974; 23:1150-2.
96. Smith RD, Konoplev S, DeCourten-Myers G, et al. West Nile virus encephalitis with myositis and orchitis. Human Pathol 2004; 35:254-38.
97. Brandt AL, Martyak N, Westhoff J, et al. West Nile virus. Military Medicine 2004; 169:261-4.
98. Crichlow R, Bailey J, Gardner C. Cerebrospinal fluid neurtrophilic pleocytosis in hospitalized West Nile virus patients. JAm Board Fam Pract 2004; 17:570-2.
99. Procop GW, Yen-Lieberman B, Prayson RA, et al. Mollaret-like cells in patients with West Nile virus infection. Emerg Infec Dis 2004; 10:753-4.
100. Asnis DA, Conetta R, Waldman G, et al. The West Nile virus encephalitis outbreak in the United States (1999-2000) from flushing, New York, to beyond its borders. Ann NY Acad Sci 2001; 161-71.
101. Cunha BA, Minnaganti V, Johnson DJ, et al. Profound and prolonged lymphocytopenia with West Nile encephalitis. Clin Infect Dis 2000; 31: 1116-7.
102. Cunha BA, McDermott BP, Mohan SS. Prognostic importance of lymphopenia in West Nile encephalitis. Am J Med 204; 117:710-1.
103. Guarner J, Shieh, W-J, Hunter S, et al. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Human Pathology 2004; 35:983-90.
104. Centers for Disease Control and Prevention/Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46[rr-10]:1-55.
105. Martin DA, Biggerstaff BJ, Allen B, et al. Use of immunoglobulin m crossreactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 2002; 9:544-9.
106. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin in antibody in confirmed West Nile virus encephalitis cases. EID 2003; 9(3):376-9.
107. Klee AN, Maldin B, Edwin B, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004; 10:1405-11.
108. Kapoor H, Signs K, Somsel P, et al. Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virology 2004; 31:289-91.
109. Batuello JT. Increased serum lipase in West Nile virus infection. N Eng J Med 2005; 352:420-1.
110. Cunha BA, Sachdev B, Canario D. Serum ferritin levels I West Nile encephalitis. Clinical Microbiology and Infection 2004; 10:184-6.
111. Medarov BI, Multz AS, Brown W, et al. West Nile meningoencephalitis and rhabdomyolsis. Lancet 2005; 5:2.
112. Sherman-Weber S, Axelrod P. Central diabetes insipidus complicating West Nile encephalitis. Clinic Infect Dis 2004; 38:1042-3.
113. Sampson BA, Ambrosi C, Charlot A, et al. The pathology of human West Nile virus infection. Human Pathology 2000; 31:527-31.
114. Sampson BA, Nields H, Armbrustmacher V, et al. Muscle weakness I West Nile encephalitis is due to destruction of motor neurons. Human Pathology 2003; 34:628-9.
115. Fratkin JD, Leis AA, Stokic DS, et al. Spinal cord neuropathology in human West Nile virus infection. Arch Pathol Lab Med 2004; 128:533-7.
116. Huang C, Slater B, Rudd R, et al. A first isolation of West Nile virus from a Patient with encephalitis in the United States. Emerg Infect Dis 2002; 8: 1367-71.
117. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro [letter]. Emerg Infect Dis 2002; 8:107-8.
118. Hrnicek MJ, Mailliard ME. Acute West Nile virus in two patients receiving interferon and ribavirin for chronic hepatitis C. Am J Gastro 2004; 99:957.
119. Pyrgos V, Younus F. High dose steroid in the management of acute flaccid paralysis due to the West Nile virus infection. Scand J Infect Dis 2004; 36:509-12.
120. Hoke CH, VaughnDW, Nisalak A, et al. The effect of high dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus. J Infect Dis 1992; 165:631-7.
121. Shimoni Z, Niven MJ, Pitlick S, et al. Treatment of West Nile virus encephalitis with intravenous gammaglobulin. Emerg Infect Dis 2001; 7:759.
122. Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J infect Dis 2003; 188:1-4.
123. Jackson AC. Therapy of West Nile virus infection. Can J Neruol Sci 2004; 31: 131-4.
124. Oliphant T, Engle M, Nybakken GE, et al. Development of a humanized monoclonal antibody with therapeutic potential against the West Nile virus. Nature Medicine, May 2005.
125. Monath TP. Prospects for development of a vaccine against the West Nile virus. Ann NY Acad Sci 2001; 951:1-12.
126. Pletnev AG, Putnak R, Speicher J, et al. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci USA. 2002; 99:3036-41.
127. Kanesa-Thasan N, Putnak JR, Mangiafico JA, et al. Short report: Absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg 2002; 66:115-6.
128. Ng T, Hathaway D, Jennings N, et al. Equine vaccine for West Nile virus. Dev Biol Vasel 2003; 114:221-7.
129. Karpati AM, Perrin MC, Matte T, et al. Pesticide spraying for West Nile virus control and emergency department asthma visits in New York City, 2000. Environ Health Perspect 2004; 112:1183-7.
130. McGready R, Hamilton KA, Simpson JA, et al. Safety of the insect repellent N, N-Diethyl-M-Toluamide (DEET) in pregnancy. Am J Trop Med Hyg 2001; 65:285-9.
131. Gubler DJ. Human arbovirus infections worldwide. Ann NY Acad Sci 2001; 951:13-24.
132. Epstein PR. West Nile virus and the climate. J Urban Health 2001; 78:367-71.